Joel A. Weinthal, MD
Dr. Weinthal received his medical degree in 1985 from Columbia University College of Physicians and Surgeons in New York City. He completed his pediatrics internship and residency at Stanford University Hospital in California and completed his hematology/oncology fellowship at the Children’s Hospital of Los Angeles in 1991. During this period he won the McAllister Research Fellowship Award in 1990 and the Medical Staff Research Award from the Children’s Hospital of Orange County in 1992. He was on the Pediatric Hematology/Oncology and Bone Marrow Transplantation faculty at the Children’s Hospital of Orange County from 1991 - 1995 where he directed the Stem Cell Program. He is currently serving as the Stem Cell laboratory director and director of apheresis for Medical City Dallas Hospital.
Dr. Weinthal received his medical degree in 1985 from Columbia University College of Physicians and Surgeons in New York City. He completed his pediatrics internship and residency at Stanford University Hospital in California and completed his hematology/oncology fellowship at the Children’s Hospital of Los Angeles in 1991. During this period he won the McAllister Research Fellowship Award in 1990 and the Medical Staff Research Award from the Children’s Hospital of Orange County in 1992. He was on the Pediatric Hematology/Oncology and Bone Marrow Transplantation faculty at the Children’s Hospital of Orange County from 1991 - 1995 where he directed the Stem Cell Program. He is currently serving as the Stem Cell laboratory director and director of apheresis for Medical City Dallas Hospital.
Dr. Weinthal is a member of the American Society of Hematology. He is a Fellow of the American Academy of Pediatrics with subspecialty certification in pediatric hematology/oncology.
Dr. Weinthal’s research interests include high risk childhood leukemia, minimal residual disease detection post transplantation, novel uses of cytokines, and pediatric supportive care issues. He has published articles in numerous journals including Blood, Journal of Clinical Oncology, and Bone Marrow Transplantation.
Dr. Weinthal’s recent research emphasis has been the study of umbilical cord blood transplantation. He is the principle investigator for the Medical City Children’s Hospital for the Children’s National Institute of Health COBLT (cord blood transplant) Study, and serves on the National Institute of Health Steering Committee for COBLT.
Pramod K. Mistry, MD, PhD, FRCP
Pramod Mistry is a professor of pediatrics and medicine, chief, Section of Pediatric Gastroenterology, Hepatology and Nutrition at Yale School of Medicine. He is also the director of the Inherited Metabolic Liver Disease Clinic. Dr Mistry received his PhD and MD degrees from University of London, England, at St Thomas’s Hospital School of Medicine and Royal Free Hospital School of Medicine, respectively. Previously, he was the attending physician and the director of the Comprehensive Gaucher Disease Center at Mount Sinai School of Medicine, New York (1998-2001). He has a long-standing interest in Gaucher Disease. He is member of the Board of International Gaucher Registry, National Gaucher Foundation and Project Hope Humanitarian Initiative in Gaucher Disease.